US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

What To Know: FDA Compounding Panel Weighs Peptides No Photo Available

Dan McKay

A panel advising the U.S. Food and Drug Administration will weigh in this week on a push to expand legal access to seven peptides that... (more story)

This Week's Healthcare Earnings: UnitedHealth, J&J, Elevance No Photo Available

Yeji Jesse Lee

Payors UnitedHealth and Elevance and pharma giant Johnson & Johnson all raised their 2026 guidance after positive second quarters. Law... (more story)

Wyeth's Patent Loss Has Attys Focusing On Dosage No Photo Available

Dani Kass

The Federal Circuit's holding that a Pfizer unit's cancer treatment patents are invalid highlights the risk of including dosages in pa... (more story)